Compare Axon Peptide Labs Tesamorelin research listings by format, current price, stock and batch documentation. Tesamorelin is listed on this site as Tesamorelin 10mg (vial) and Tesamorelin 10mg (Pen).
For laboratory research use only. Not for human or animal consumption. Axon Peptide Labs does not provide dosing or administration guidance.
- Compound: Tesamorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), studied in GHRH receptor and GH-axis research
- Formats: 10mg vial and 10mg pen
- Documentation: batch COAs shown on the product page and in the COA library when available
Tesamorelin Vial
Tesamorelin in a 10mg vial.
Tesamorelin 10mg
Tesamorelin Pen
Tesamorelin supplied in pen format, 10mg.
Tesamorelin 10mg (Pen)
Laboratory Supplies
Bacteriostatic water, listed separately.
Bacteriostatic Water 10ml
How to Choose a Tesamorelin Listing
Pick the format (vial or pen) you need, then check the current price, stock status and COA shown on that listing. The vial and pen are separate products, so confirm the exact item in your cart before checkout. For more detail, see the Tesamorelin Canada product guide.
Batch Documentation
Available COAs for Tesamorelin are shown on the product page and in the COA library. See Lab Standards for how testing documentation is published. Match the product name, strength and batch to the document before relying on it.
Tesamorelin FAQ
Where can I buy Tesamorelin in Canada?
Axon Peptide Labs lists Tesamorelin 10mg as a vial and as a pen on this page. Current shipping options and costs are shown at checkout.
What is Tesamorelin?
Tesamorelin is a synthetic peptide analog of GHRH. It is studied in GHRH receptor signaling and growth hormone axis research.
Is there a COA for Tesamorelin?
Available batch documentation is shown on each Tesamorelin product page and in the COA library.
Is Tesamorelin for human use?
No. All products are sold strictly for laboratory research use and are not for human or animal consumption. Axon Peptide Labs does not provide dosing or administration guidance.
